Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILLUMINATE: Ipragliflozin + Metformin in T2DM
NCT01135433Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- May 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ipragliflozin in type 2 diabetes mellitus (T2DM), sponsored by Astellas Pharma. Started May 2010; status: completed.
02
Drugs
ipragliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01135433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01135433.